Bottom line
DSCYX vs DAGVX: the short answer
DSCYX (BNY Mellon Opportunistic Small Cap Fund) and DAGVX (BNY Mellon Dynamic Value Fund) are both mutual funds.
DSCYX is cheaper at 0.78% vs 0.93% — a difference of $15 a year per $10,000 invested.
Over five years, DAGVX returned +11.8% a year vs +5.5% for DSCYX.
DAGVX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
DSCYX vs DAGVX side by side
| DSCYX | DAGVX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BNY Mellon / Dreyfus | BNY Mellon / Dreyfus |
| Category | Small-Cap | Large Value |
| Expense ratio | 0.78% | 0.93% |
| Annual cost per $10k | $78 | $93 |
| 10-yr cost on $10k (prospectus) | $1,075 | $1,662 |
| Max front load | — | 5.75% |
| 12b-1 fee | — | 0% |
| 1-yr return | +4.0% | +9.1% |
| 5-yr return (annualized) | +5.5% | +11.8% |
| 10-yr return (annualized) | +6.1% | +10.1% |
| Best quarter | — | +20.5% |
| Worst quarter | — | −30.7% |
| Net assets (fund) | — | $12.1B |
| Number of holdings | — | 85 |
| Portfolio turnover | 68% | 95% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
DSCYX and DAGVX share none of their top holdings.
DSCYX top 10
DAGVX top 10
- Jp Morgan Chase & Company — 3.41%
- Amazon.com Inc — 3.31%
- Unitedhealth Group Inc — 3.14%
- Cisco Systems Inc — 2.92%
- Applied Materials Inc — 2.75%
- Berkshire Hathaway Inc — 2.61%
- Johnson & Johnson — 2.51%
- Assurant Inc — 2.50%
- Texas Instruments Inc — 2.45%
- Slb Ltd — 2.32%
FAQ
What is the difference between DSCYX and DAGVX?
DSCYX (BNY Mellon Opportunistic Small Cap Fund) and DAGVX (BNY Mellon Dynamic Value Fund) are both mutual funds. DSCYX is cheaper at 0.78% vs 0.93% — a difference of $15 a year per $10,000 invested.
Which is cheaper, DSCYX or DAGVX?
DSCYX has the lower expense ratio (0.78%).
Should I own both DSCYX and DAGVX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.